Clearstead Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-25
| Closed | -$1.04K | – | 1548 |
|
|
2023
Q2 | $1.04K | Hold |
25
| – | – | ﹤0.01% | 1244 |
|
|
2023
Q1 | $1.5K | Hold |
25
| – | – | ﹤0.01% | 1183 |
|
|
2022
Q4 | $1.83K | Hold |
25
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 1085 |
|
|
2022
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 1116 |
|
|
2022
Q1 | $2K | Buy |
25
+5
| +25% | +$400 | ﹤0.01% | 1217 |
|
|
2021
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 1137 |
|
|
2021
Q2 | $4K | Hold |
20
| – | – | ﹤0.01% | 923 |
|
|
2021
Q1 | $3K | Buy |
20
+10
| +100% | +$1.5K | ﹤0.01% | 924 |
|
|
2020
Q4 | $2K | Hold |
10
| – | – | ﹤0.01% | 894 |
|
|
2020
Q3 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 849 |
|